United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - loperamide hydrochloride - oral capsule - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - loperamide hydrochloride; simeticone - oral tablet - 2mg ; 125mg

Ireland - English - HPRA (Health Products Regulatory Authority)

johnson & johnson (ireland) limited - loperamide hydrochloride; simeticone - tablet - 2 mg/125 milligram(s) - antipropulsives; loperamide, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

jntl consumer health i (ireland) limited - loperamide hydrochloride; simeticone - tablet - antipropulsives; loperamide, combinations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - loperamide hydrochloride; simeticone - oral tablet - 2mg ; 125mg

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - loperamide hydrochloride (unii: 77ti35393c) (loperamide - unii:6x9oc3h4ii) - loperamide hydrochloride 2 mg - loperamide hydrochloride capsules are indicated for the control and symptomatic relief of acute nonspecific diarrhea in patients 2 years of age and older and of chronic diarrhea in adults associated with inflammatory bowel disease. loperamide hydrochloride is also indicated for reducing the volume of discharge from iloestomies. loperamide hydrochloride capsules are contraindicated in: • pediatric patients less than 2 years of age due to the risks of respiratory depression and serious cardiac adverse reactions (see warnings). • patients with a known hypersensitivity to loperamide hydrochloride or to any of the excipients. • patients with abdominal pain in the absence of diarrhea. • patients with acute dysentery, which is characterized by blood in stools and high fever. • patients with acute ulcerative colitis. • patients with bacterial enterocolitis caused by invasive organisms including salmonella, shigella, and campylobacter. • patients with ps

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - loperamide hydrochloride (unii: 77ti35393c) (loperamide - unii:6x9oc3h4ii) - loperamide hydrochloride 2 mg - loperamide hydrochloride capsules are indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease. loperamide hydrochloride capsules are also indicated for reducing the volume of discharge from ileostomies. loperamide hydrochloride capsules are contraindicated in patients with known hypersensitivity to loperamide hydrochloride or to any of the excipients. loperamide hydrochloride is contraindicated in patients with abdominal pain in the absence of diarrhea. loperamide hydrochloride is not recommended in infants below 24 months of age. loperamide hydrochloride should not be used as the primary therapy: - in patients with acute dysentery, which is characterized by blood in stools and high fever, - in patients with acute ulcerative colitis, - in patients with bacterial enterocolitis caused by invasive organisms including salmonella, shigella, and campylobacter, - in patients with pseudomembranous colitis associated with the us

United States - English - NLM (National Library of Medicine)

direct rx - loperamide hydrochloride (unii: 77ti35393c) (loperamide - unii:6x9oc3h4ii) - loperamide hydrochloride 2 mg - loperamide hydrochloride capsules are indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease. loperamide hydrochloride capsules are also indicated for reducing the volume of discharge from ileostomies. loperamide hydrochloride capsules are contraindicated in patients with a known hypersensitivity to loperamide hydrochloride or to any of the excipients. loperamide hydrochloride is contraindicated in patients with abdominal pain in the absence of diarrhea. loperamide hydrochloride is not recommended in infants below 24 months of age. loperamide hydrochloride should not be used as the primary therapy: - in patients with acute dysentery, which is characterized by blood in stools and high fever, - in patients with acute ulcerative colitis, - in patients with bacterial enterocolitis caused by invasive organisms including salmonella, shigella, and campylobacter, - in patients with pseudomembranous colitis associated with the u

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - loperamide hydrochloride (unii: 77ti35393c) (loperamide - unii:6x9oc3h4ii) - loperamide hydrochloride 2 mg - loperamide hydrochloride capsules are indicated for the control and symptomatic  relief of acute nonspecific diarrhea in patients 2 years of age and older and of chronic diarrhea in adults associated with inflammatory  bowel disease. loperamide hydrochloride capsules are also indicated for reducing the volume of discharge from  ileostomies. loperamide hydrochloride capsules are contraindicated in: loperamide is not a controlled substance. loperamide is a mu-opioid agonist. a human abuse potential study of loperamide hydrochloride at single doses up to 60 mg (3.75 times the recommended maximum adult dosage of 16 mg per day) was compared, in a double-blind cross-over design using nine subjects who had been active opiate users, to a threshold dose of codeine sulfate at 120 mg (96 mg base) or placebo. this resulted in one subject (11%) feeling a drug on placebo and identifying it as "dope" (heroin) and liking it slightly. codeine was felt by 56% of subjects and identified as "dope" by 44%. loperamide was felt by 44% of subjects and identified as "dope" by 11% and possibly dope mixed with some other kind of drug by another 22%. loperamide abuse and misuse have been reported, especially at doses of 60 mg or greater. loperamide can have greater cns opioid effects at higher doses or with coadministration of drugs that increase systemic exposure and/or increase cns penetration of loperamide (through inhibition of the cyp450 enzyme system or inhibition of p-glycoprotein). loperamide is primarily being misused for relief from opioid withdrawal, and abused by a few users who obtain some (reportedly mild-moderate) level of euphoria. in animals, parenteral administration of loperamide hydrochloride can cause physical dependence, cross-tolerance to opioids, and all the other pharmacologic effects typical of mu-opioid agonists. studies in morphine-dependent monkeys demonstrated that loperamide hydrochloride at doses above those recommended for humans prevented signs of morphine withdrawal.

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, llc dba vangard labs - loperamide hydrochloride (unii: 77ti35393c) (loperamide - unii:6x9oc3h4ii) - loperamide hydrochloride 2 mg - loperamide hydrochloride capsules are indicated for the control and symptomatic  relief of acute nonspecific diarrhea in patients 2 years of age and older and of chronic diarrhea in adults associated with inflammatory  bowel disease. loperamide hydrochloride capsules are also indicated for reducing the volume of discharge from  ileostomies. loperamide hydrochloride capsules are contraindicated in: - pediatric patients less than 2 years of age due to the risks of respiratory depression and serious cardiac adverse reactions (see warnings). - patients with a known hypersensitivity to loperamide hydrochloride or to any of the excipients. - patients with abdominal pain in the absence of diarrhea. - patients with acute dysentery, which is characterized by blood in stools and high fever. - patients with acute ulcerative colitis. - patients with bacterial enterocolitis caused by invasive organisms including salmonella , shigella , and campylobacter . - patients with pseudomembranous colitis (e.g., clostridium difficl